Thomas Woliver
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Acute Myeloid Leukemia Research 1
-
- Protein Degradation and Inhibitors 6
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Arvin S. Glicksman (1 shared paper)Ivor Royston (1 shared paper)Janet Cuttner (1 shared paper)CA Schiffer (1 shared paper)E. S. Henderson (1 shared paper)FR Davey (1 shared paper)Rose Ruth Ellison (1 shared paper)Rosemarie Mick (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (2 papers)Leukemia (1 paper)Supportive Care in Cancer (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United States
In The Last Decade
Thomas Woliver
9 papers receiving 155 citations
Peers
Comparison fields: 5 of 41
- Hematology 99
- Oncology 73
- Genetics 25
- Public Health, Environmental and Occupational Health 68
- Pediatrics, Perinatology and Child Health 23
Countries citing papers authored by Thomas Woliver
This map shows the geographic impact of Thomas Woliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Woliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Woliver more than expected).
Fields of papers citing papers by Thomas Woliver
This network shows the impact of papers produced by Thomas Woliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Woliver. The network helps show where Thomas Woliver may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Woliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 82 | |
| 2 | 2012 | 32 | |
| 3 | 2014 | 27 | |
| 4 | 2017 | 9 | |
| 5 | 2015 | 4 | |
| 6 | 2015 | 2 | |
| 7 | 2010 | 2 | |
| 8 | 2011 | 1 | |
| 9 | 2014 | 1 |
About Thomas Woliver
Thomas Woliver is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 160 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers), Cancer Treatment and Pharmacology (4 papers), Peptidase Inhibition and Analysis (4 papers), Histone Deacetylase Inhibitors Research (1 paper), Acute Myeloid Leukemia Research (1 paper), Dendrimers and Hyperbranched Polymers (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hematology (99 citations), Oncology (73 citations), Genetics (25 citations), Public Health, Environmental and Occupational Health (68 citations) and Pediatrics, Perinatology and Child Health (23 citations). Thomas Woliver has collaborated with scholars based in United States. Frequent co-authors include Arvin S. Glicksman, Ivor Royston, Janet Cuttner, CA Schiffer, E. S. Henderson, FR Davey, Rose Ruth Ellison, Rosemarie Mick, R T Silver and Robert Vescio. Their work appears in journals such as Journal of Clinical Oncology, Blood, Leukemia, Supportive Care in Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.